rs80111665
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001009944.3(PKD1):c.5847C>T(p.Ser1949=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00258 in 1,587,532 control chromosomes in the GnomAD database, including 70 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0041 ( 13 hom., cov: 33)
Exomes 𝑓: 0.0024 ( 57 hom. )
Consequence
PKD1
NM_001009944.3 synonymous
NM_001009944.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.46
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 16-2109320-G-A is Benign according to our data. Variant chr16-2109320-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 256983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2109320-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-3.46 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00408 (622/152350) while in subpopulation EAS AF= 0.0539 (279/5174). AF 95% confidence interval is 0.0487. There are 13 homozygotes in gnomad4. There are 370 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 622 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.5847C>T | p.Ser1949= | synonymous_variant | 15/46 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.5847C>T | p.Ser1949= | synonymous_variant | 15/46 | 1 | NM_001009944.3 | ENSP00000262304 | P5 |
Frequencies
GnomAD3 genomes AF: 0.00409 AC: 622AN: 152232Hom.: 13 Cov.: 33
GnomAD3 genomes
AF:
AC:
622
AN:
152232
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00663 AC: 1518AN: 228966Hom.: 35 AF XY: 0.00588 AC XY: 745AN XY: 126784
GnomAD3 exomes
AF:
AC:
1518
AN:
228966
Hom.:
AF XY:
AC XY:
745
AN XY:
126784
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00242 AC: 3475AN: 1435182Hom.: 57 Cov.: 34 AF XY: 0.00236 AC XY: 1679AN XY: 711902
GnomAD4 exome
AF:
AC:
3475
AN:
1435182
Hom.:
Cov.:
34
AF XY:
AC XY:
1679
AN XY:
711902
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00408 AC: 622AN: 152350Hom.: 13 Cov.: 33 AF XY: 0.00497 AC XY: 370AN XY: 74492
GnomAD4 genome
AF:
AC:
622
AN:
152350
Hom.:
Cov.:
33
AF XY:
AC XY:
370
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
77
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 21, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 14, 2020 | This variant is associated with the following publications: (PMID: 11012875, 22383692, 18837007, 22185115) - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Polycystic kidney disease, adult type Benign:1
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jan 29, 2019 | - - |
Polycystic kidney disease Benign:1
Benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKD1 p.Ser1949= variant was identified in 1 of 460 proband chromosomes (frequency: 0.002) from individuals or families with ADPKD, and was present in 1 of 92 control chromosomes (frequency: 0.01) from healthy individuals (Rossetti_2012_22383692, Phakdeekitcharoen_2000_11012875). The variant was also identified in dbSNP (ID: rs80111665) as “With Likely benign allele”, ClinVar (classified as benign by ARUP Laboratories and likely benign by PreventionGenetics), and the ADPKD Mutation Database (classified as likely neutral). The variant was not identified in GeneInsight-COGR, LOVD 3.0, or PKD1-LOVD databases. The variant was identified in control databases in 1665 of 257370 chromosomes (38 homozygous) at a frequency of 0.006 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include African in 3 of 22624 chromosomes (freq: 0.0001), Other in 41 of 6190 chromosomes (freq: 0.007), Latino in 112 of 33994 chromosomes (freq: 0.003), European Non-Finnish in 123 of 119088 chromosomes (freq: 0.001), Ashkenazi Jewish in 53 of 9568 chromosomes (freq: 0.006), East Asian in 1005 of 18588 chromosomes (freq: 0.05), European Finnish in 280 of 17560 chromosomes (freq: 0.02), and South Asian in 48 of 29758 chromosomes (freq: 0.002). In addition we cannot be certain that data from control databases is specific to PKD1 and not from one of the six PKD1 pseudogenes. The variant occurs outside of the splicing consensus sequence and 3 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing; this is not very predictive of pathogenicity. The p.Ser1949= variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. In summary, based on the above information this variant meets our laboratory criteria to be classified as benign. - |
PKD1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at